Search results
Doctors Test the Limits of What Obesity Drugs Can Fix
New York Times· 4 days ago“Obesity first” doctors say they start with one pill, to treat obesity, and often find other chronic...
New JAK 1 Inhibitor Proves Promising in Phase 3 RA Trial
Medscape· 3 days agoThe highly selective oral Janus kinase (JAK) inhibitor SHR0302 (ivarmacitinib) enables more patients...
Navidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024 -...
Benzinga· 1 day agoNavidea Biopharmaceuticals, Inc. NAVB ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it will ...
Sunset coming for rare pediatric disease treatment vouchers
The Center Square· 6 hours agoPennsylvania Democratic Sen. Bob Casey, however, wants to revive the program for another decade –...
Shoring up blood vessels may offer new approach for treating autoimmune rheumatic diseases
Medical Xpress· 5 days agoA study from physician-scientists at the Hospital for Special Surgery (HSS) points to a potential...
In a 'gold rush' for treating bowel disease, AbbVie clears one more stage
Crain s Chicago Business· 2 days agoWith the arrival of biosimilar competition for its blockbuster drug Humira, AbbVie has said much of its sales growth potential lies with these two anti-inflammatories. In ...
Phase 3 Trial Supports Ixekizumab in Juvenile PsA, ERA
Medscape· 2 days agoIxekizumab (Taltz), an interleukin-17A inhibitor that's already approved for the treatment of...
Sjogren's Syndrome
Health· 3 days agoPeople with Sjogren’s syndrome are also at increased risk of yeast infections (candidiasis), both orally and vaginally, which may require antifungal ...
Joint pain at night: Causes and treatment
Medical News Today· 3 days agoJoint pain at night has several causes, including a person’s sleeping position, bedding used, and existing medical conditions, such as arthritis....
Baysient® Launches Therapeutic Drug Monitoring Software for Oncology Biologics
Benzinga· 4 days agoBaysient®, a leading provider of therapeutic drug monitoring (TDM) software, today announced the launch of TuMinimize™, a web-based nomogram/algorithm designed to optimize ...